European public procurement and grants data from official registers · Data as of 19 November 2026; updated daily.

Market report

Dermatological drug tenders in Czechia — market report, February 2025

Dermatological drug tenders in Czechia in February 2025: 9,302 tenders published (+97% month on month, +37% year on year), estimated at €122,469 in total, and 9,292 contracts awarded (+97% month on month, +37% year on year), worth €86,091,598 (contract value). Buyers with the most tenders: Krajská nemocnice T. Bati, a. s. (3,712), Fakultní nemocnice Bulovka (2,227) and Krajská zdravotní, a.s. (716); most contracts won: ViaPharma s.r.o. (404), ROCHE s.r.o. (249) and Merck Sharp & Dohme s.r.o. (127). On average 1.8 bids per contract; 40% of contracts had a single bid. Report made on 27 October 2026.

Tenders published
9,302
Contracts awarded
9,292
Contract value contract
€86,091,598
Bids per contract
1.8
Tenders published per month
05K10KFeb 24: 6,766Feb 24: 6,766Feb 24Mar 24: 6,332Mar 24: 6,332Mar 24Apr 24: 6,740Apr 24: 6,740Apr 24May 24: 6,773May 24: 6,773May 24Jun 24: 6,695Jun 24: 6,695Jun 24Jul 24: 5,647Jul 24: 5,647Jul 24Aug 24: 5,777Aug 24: 5,777Aug 24Sep 24: 5,695Sep 24: 5,695Sep 24Oct 24: 7,005Oct 24: 7,005Oct 24Nov 24: 6,299Nov 24: 6,299Nov 24Dec 24: 6,565Dec 24: 6,565Dec 24Jan 25: 4,714Jan 25: 4,714Jan 25Feb 25: 9,302Feb 25: 9,3029,302Feb 25
Contracts awarded per month
05K10KFeb 24: 6,759Feb 24: 6,759Feb 24Mar 24: 6,341Mar 24: 6,341Mar 24Apr 24: 6,746Apr 24: 6,746Apr 24May 24: 6,771May 24: 6,771May 24Jun 24: 6,702Jun 24: 6,702Jun 24Jul 24: 5,647Jul 24: 5,647Jul 24Aug 24: 5,776Aug 24: 5,776Aug 24Sep 24: 5,682Sep 24: 5,682Sep 24Oct 24: 7,008Oct 24: 7,008Oct 24Nov 24: 6,301Nov 24: 6,301Nov 24Dec 24: 6,569Dec 24: 6,569Dec 24Jan 25: 4,725Jan 25: 4,725Jan 25Feb 25: 9,292Feb 25: 9,2929,292Feb 25

The highlighted bar is February 2025. Hover a bar for its figure; the table below has every value.

FigureFebruary 2025January 2025ChangeFebruary 2024Change
Tenders published9,3024,714+97%6,766+37%
Estimated value€122,469€584,738-79%€80,693,989-100%
Buyers3029+3%32-6%
Contracts awarded9,2924,725+97%6,759+37%
Contract value (contract)€86,091,598€82,678,669+4%€57,603,438+49%
Winners267229+17%282-5%
Bids per contract1.81.7———
Single-bid contracts40%69%———

Buyers with the most tenders

Companies with the most contracts

Where the tenders were

  • Hlavní město Praha 13
  • Olomoucký kraj 2

Procedures

  • not stated 9,287
  • Open procedure 15

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Dermatological and musculoskeletal drugs

Questions and answers

How many dermatological drug tenders were published in Czechia in February 2025?
9,302 (by 30 buyers); for comparison, January 2025: 4,714, February 2024: 6,766.
Who won the most dermatological drug tenders in Czechia in February 2025?
By number of contracts: ViaPharma s.r.o. (404), ROCHE s.r.o. (249), Merck Sharp & Dohme s.r.o. (127), Janssen-Cilag s.r.o. (126) and Amgen s.r.o. (122); 267 companies won contracts in all.
Which buyers published the most dermatological drug tenders in February 2025?
Krajská nemocnice T. Bati, a. s. (3,712), Fakultní nemocnice Bulovka (2,227), Krajská zdravotní, a.s. (716), Fakultní nemocnice Brno (311) and Nemocnice České Budějovice, a.s. (283).
How competitive were dermatological drug tenders in Czechia in February 2025?
On average 1.8 bids per contract (5 contracts with a known number of bids); 40% of contracts had a single bid.
What were the contracts worth in February 2025?
€86,091,598 (contract value, 9,292 contracts); median about €2,700.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.